Literature DB >> 7700949

Strain differences in the analgesic and reinforcing action of morphine in mice.

S Semenova1, A Kuzmin, E Zvartau.   

Abstract

The analgesic and reinforcing effects of morphine were compared in four strains of mice (C57BL/6, BALB/c, DBA, CBA). The analgesic action of morphine was measured in tail immersion (49 degrees C), hot plate (60 degrees C), and tail clip (four-point scale of nociceptive response) tests. The reinforcing action of morphine was studied in i.v. self-administration and conditioned place preference techniques. The results demonstrate strain differences in the analgesic and reinforcing action of morphine in mice. The relative rank order of the strains varied for the several tests as well as for the morphine effects. The lack of correlation between analgesic and reinforcing action of morphine in inbred strains supports the conclusion that analgesia and reinforcement are separate processes with different genetic control.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7700949     DOI: 10.1016/0091-3057(94)00221-4

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  17 in total

1.  Susceptibility to conditioned place preference induced by addictive drugs in mice of the C57BL/6 and DBA/2 inbred strains.

Authors:  C Orsini; A Bonito-Oliva; D Conversi; S Cabib
Journal:  Psychopharmacology (Berl)       Date:  2005-10-14       Impact factor: 4.530

2.  The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice.

Authors:  Neil E Paterson; Svetlana Semenova; Fabrizio Gasparini; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2003-04-08       Impact factor: 4.530

3.  Impact of strain and D-amphetamine on impulsivity (delay discounting) in inbred mice.

Authors:  Christa M Helms; Jamie M Reeves; Suzanne H Mitchell
Journal:  Psychopharmacology (Berl)       Date:  2006-08-17       Impact factor: 4.530

4.  CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.

Authors:  Maciej Gonek; Virginia D McLane; David L Stevens; Kumiko Lippold; Hamid I Akbarali; Pamela E Knapp; William L Dewey; Kurt F Hauser; Jason J Paris
Journal:  Brain Behav Immun       Date:  2017-11-13       Impact factor: 7.217

5.  Forebrain PENK and PDYN gene expression levels in three inbred strains of mice and their relationship to genotype-dependent morphine reward sensitivity.

Authors:  Agnieszka Gieryk; Barbara Ziolkowska; Wojciech Solecki; Jakub Kubik; Ryszard Przewlocki
Journal:  Psychopharmacology (Berl)       Date:  2009-12-09       Impact factor: 4.530

6.  Regional mRNA expression of the endogenous opioid and dopaminergic systems in brains of C57BL/6J and 129P3/J mice: strain and heroin effects.

Authors:  S D Schlussman; J Cassin; Y Zhang; O Levran; A Ho; M J Kreek
Journal:  Pharmacol Biochem Behav       Date:  2011-07-23       Impact factor: 3.533

7.  Atipamezole reverses ketamine-dexmedetomidine anesthesia without altering the antinociceptive effects of butorphanol and buprenorphine in female C57BL/6J mice.

Authors:  Jenelle M Izer; Tiffany L Whitcomb; Ronald P Wilson
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-11       Impact factor: 1.232

8.  Essential role for RGS9 in opiate action.

Authors:  Venetia Zachariou; Dan Georgescu; Nick Sanchez; Zia Rahman; Ralph DiLeone; Olivier Berton; Rachael L Neve; Laura J Sim-Selley; Dana E Selley; Stephen J Gold; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

9.  Qualitative differences between C57BL/6J and DBA/2J mice in morphine potentiation of brain stimulation reward and intravenous self-administration.

Authors:  Greg I Elmer; Jeanne O Pieper; Lindsey R Hamilton; Roy A Wise
Journal:  Psychopharmacology (Berl)       Date:  2009-12-15       Impact factor: 4.530

10.  Motivational effects of opiates in conditioned place preference and aversion paradigm--a study in three inbred strains of mice.

Authors:  Wojciech Solecki; Anna Turek; Jakub Kubik; Ryszard Przewlocki
Journal:  Psychopharmacology (Berl)       Date:  2009-09-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.